BILE DUCT CANCER RECURRENT

BILE DUCT CANCER RECURRENT was reported 28 times

BILE DUCT CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 7 0.0003
1 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
2 Chloride Channel Activator [EPC] 1 0.0001
3 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
4 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
5 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
6 Oxazolidinone Antibacterial [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 6 0.0000
8 Muscle Relaxant [EPC] 1 0.0000
9 Aromatic Amino Acid [EPC] 1 0.0000
10 Glycopeptide Antibacterial [EPC] 1 0.0000
11 Integrin Receptor Antagonist [EPC] 1 0.0000
12 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
13 Parathyroid Hormone Analog [EPC] 1 0.0000
14 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
15 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
16 Leukocyte Growth Factor [EPC] 1 0.0000
17 Aldosterone Antagonist [EPC] 1 0.0000
18 Azole Antifungal [EPC] 1 0.0000
19 Proton Pump Inhibitor [EPC] 3 0.0000
20 Loop Diuretic [EPC] 2 0.0000
21 Corticosteroid [EPC] 5 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
23 Factor Xa Inhibitor [EPC] 1 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
25 Benzodiazepine [EPC] 2 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
27 Insulin Analog [EPC] 1 0.0000
28 Atypical Antipsychotic [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000